Assembly Biosciences, Inc.
ASMBBiotechnology
$20.86+1.41%As of Oct 29vs prior close
- Market cap
- $424.7M
- P/E (TTM)
- –
- From 52W high
- −45.82%
- EPS (LTM)
- $1.21
- Revenue (YE25)
- $72.3M
- Dividend yield
- 0.00%
Nomior Score
36
Patient ValueSpeculativeBottom 23% of the scored universe
Growth18
Quality58
Value66
Momentum28
Resilience44
Growth
$72.3Mrevenue, YE25
YE16 $0YE25 $72.3M
Connections
Revenue to profitQ2 YE26
The operating loss was 47% of revenue, narrower by 68 pts on a year.
Who owns it
2funds